Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LAPATINIB for Neoplasm: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 5 adverse event reports in the FDA FAERS database where LAPATINIB was used for Neoplasm.

Most Reported Side Effects for LAPATINIB

Side Effect Reports % Deaths Hosp.
Diarrhoea 382 19.3% 35 131
Disease progression 227 11.5% 37 21
Palmar-plantar erythrodysaesthesia syndrome 182 9.2% 18 24
Malignant neoplasm progression 173 8.7% 41 21
Nausea 161 8.1% 17 67
Metastases to central nervous system 160 8.1% 32 32
Neutropenia 160 8.1% 11 27
Vomiting 155 7.8% 16 67
Asthenia 148 7.5% 19 38
Fatigue 139 7.0% 13 50
Off label use 118 6.0% 12 42
Rash 108 5.5% 8 18
Thrombocytopenia 102 5.1% 8 20
Metastases to lymph nodes 95 4.8% 3 29
Metastases to lung 92 4.6% 8 10

Other Indications for LAPATINIB

Breast cancer (447) Breast cancer metastatic (434) Her2 positive breast cancer (241) Product used for unknown indication (233) Her-2 positive breast cancer (151) Invasive ductal breast carcinoma (113) Breast cancer female (37) Neoplasm malignant (33) Metastases to central nervous system (30) Colorectal cancer metastatic (25)

Other Drugs Used for Neoplasm

BEVACIZUMAB (502) ATEZOLIZUMAB (404) CYCLOPHOSPHAMIDE (385) CARBOPLATIN (283) PACLITAXEL (267) NIVOLUMAB (219) OXALIPLATIN (185) PEMBROLIZUMAB (173) LENALIDOMIDE (171) DOXORUBICIN (150)

Related Pages

LAPATINIB Full Profile All Neoplasm Drugs LAPATINIB Demographics LAPATINIB Timeline